KLRK1 and acute myeloid leukemia: In AML patients, chronic exposure to MICA/B decreases expression of NKG2D on NK cells (104) and the concentration of NKG2D soluble ligands in the peripheral blood correlates with reduced NK cell cytotoxicity in AML and CML (105).